When it comes to drug safety and epidemiology, you want real insights, not just information. OptumInsight epidemiology experts are recognized for their scientific rigor and integrity. They have appeared before the FDA, EMA, and scores of professional congresses, and their publications on drug safety, which include key product studies and research into methods, place them at the forefront of epidemiologic design and practice. OptumInsight research leaders have served as key advisors to sponsors, regulators, and payers on how to best meet a product’s safety information needs, and they stand ready to provide you with the best in reliability, clarity, data quality, and technical expertise. Read more.